+17.7%
AZN vs BBIO
+26.9%
-9.2%
-25.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.8% | +5.2% | -2.4% | +2.2% |
| 7D | +11.5% | +10.0% | +1.5% | +10.4% |
| 30D | +20.8% | +17.8% | +3.0% | +18.9% |
| 3M | +21.5% | -5.1% | +26.5% | +21.3% |
| 6M | +3.0% | +12.9% | -9.9% | +1.1% |
| YTD | +3.9% | +1.8% | +2.0% | +2.2% |
| All | +17.7% | +26.9% | -9.2% | +10.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling